Image
Noticia 3

La vitamina D de nuevo a debate tras el congreso ASBMR 2019

El congreso ASMBR (American Society for Bone and Mineral Research) tiene por costumbre realizar una sesión de debate clínico con la ECTS (European Calcified Tissues Society) sobre un tema en concreto. En esta edición del 2019, el debate se tituló:

ASBMR/ECTS Clinical Debate: Calcium and Vitamin D Should Routinely Be Part of Anti-osteoporosis Treatment Regimens.1

Defendió esta afirmación Roger Bouillon MD, PhD de la Katholieke Universiteit Leuven, Bélgica por parte de la ECTS y expuso argumentos en contra de la misma Juliet Compston MD, de la University of Cambridge School of Clinical Medicine, Reino Unido en representación de la ASMBR.

Además de en el debate, el tema de la vitamina D se trató en las sesiones de pósteres. Esta es una muestra de algunos de ellos2:

  • [FRI-73] Maternal pregnancy vitamin D supplementation is associated with greater offspring bone mineral density at 4 years: findings from the MAVIDOS trial.
  • [SAT-262] Vitamin D threshold ≥40ng/mL prevents arthralgia in aromatase inhibitors users: B-ABLE cohort study.
  • [SAT-313] Prevalence of vitamin D deficiency and inadequacy among U.S. older adults: The NHANES 2007-2014.
  • [SAT-712] Identification of factors that affect serum levels of 25-hydroxyvitamin D.
  • [SUN-267] Delta Like 1(DLK1) is a Possible Mediator of Vitamin D Effects on Bone and Energy Metabolism.
  • [SUN-715] Effects of Vitamin D3 Supplementation on Body Composition in the VITamin D and OmegA-3 Fatty Acid TriaL (VITAL).
  • [SUN-719] Vitamin D Deficiency or Insufficiency Screening Tools for Adults: A Systematic Review.
  • [SUN-796] The effect of combination therapy of PTH and vitamin D.
  • [LB MON-973] Free but not total 25hydroxyvitamin D is correlated with calcium absorption.
  • [MON-619] Study on vitamin D deficiency in Japan: relationship to age, gender, and bone mineral density.
  • [MON-722] Effect of Adiposity on Change in 25(OH) Vitamin D and Free Vitamin D Levels in the VITamin D and OmegA-3 Fatty Acid TriaL (VITAL).
  • [MON-964] Muscle health, postural stability and quality of life in vitamin D insufficient healthy women: a crosssectional comparison of the effects of elevated parathyroid levels.

Y en las siguientes presentaciones orales:

  • [1030] Vitamin D receptor signaling prevents the adverse actions of glucocorticoid excess in bone, skeletal muscle, and the heart, by interfering with the atrogene pathway.
  • [1076] Effects of Supplementation with Vitamin D3 400, 4000 or 10000 IU Daily for Three Years on Vascular Calcification in The Calgary Vitamin D Study: Secondary Analysis of a Randomized Controlled Trial.
  • [1046] VITamin D and OmegA-3 TriaL (VITAL): Effects of Vitamin D on Bone Density, Turnover and Structure.

Así como en la sesión Meet the Professor: Vitamin D and Immunity.


1 https://www.asbmr.org/official-program

https://www.asbmr.org/official-program